HAC (Russian)
RSCI (Russian)
EBSCO
DOI (USA)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

METABOLIC THERAPY IN INTEGRATED TREATMENT AND PREVENTION OF GESTATION COMPLICATIONS

Download full text PDF
Issue: 
9
Year: 
2017

M. Kaganova, Candidate of Medical Science; Professor N. Spiridonova, MD; Professor O. Lineva, MD; A. Kazakova, Candidate of Medical Sciences, S. Nesterenko, Candidate of Medical Sciences Samara State Medical University

Objectives. Estimate the likelihood of developing gestational complications in pregnant women with vomiting of pregnancy (NVP) and hyperemesis gravidarum (HG), as well as the efficiency of the metabolic therapy (cocarboxylase hydrochloride 0.025 g, riboflavin 0.002 g, α-lipoic acid 0.0012 g) in correcting these complications.

Keywords: 
obstetrics and gynecology
nausea and vomiting of pregnancy
hyperemesis gravidarum (HG)
vitamins
cocarboxylase hydrochloride
riboflavin
α-lipoic acid
fetal grow restriction (FGR)
stillbirth and small for gestational age (SGA)
pre-eclampsia
metabolic dysfunction
placental dysfunction disorder



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Gromova O.A., Kerimkulova N.V., Grishina T.R. i dr. Polozhitel'nye i otritsatel'nye vzaimodejstvija mikronutrientov i rol' vitaminno- mineral'nyh kompleksov dlja razvitija beremennosti // Vopr. ginekol., akush. i perinatol. – 2012; 11 (2): 63–70.
  2. Fan Wu, Fu-Ju Tian, Yi Lin. Oxidative Stress in Placenta: Health and Diseases // Biomed. Res. Int. – 2015; 2015: 293271. DOI: 10.1155/2015/293271PMCID: PMC4676991.
  3. Kutuzova O.A. Optimizatsija vedenija beremennyh s rannim tokiskozom putem vydelenija prediktorov tjazhelogo techenija // Aspirantskij vestnik Povolzh'ja. – 2015; 5–6: 48–56.
  4. Kushhova Zh.H. Kokarboksilaza, vitamin V2 i lipoevaja kislota v akushersko-ginekologicheskoj praktike // Lechaschij vrach. – 2010; 8: 88–90.
  5. Bolin M., Åkerud H., Cnattingius S. et al. Hyperemesis gravidarum and risks of placental dysfunction disorders: a population-based cohort study // BJOG. – 2013; 120 (5): 541–7. DOI: 10.1111/1471-0528.12132.
  6. Koren G., Piwko C., Ahn E. et al. Validation studies of the Pregnancy Unique-Quantification of Emesis (PUQE) scores // J. Obstet. Gynaecol. – 2005; 25 (3): 241–4.
  7. Ushkalova E.A., Romanova O.L., Illarionova T.S. Farmakoterapija pri toshnote i rvote u beremennyh // Vrach. – 2011; 3: 24–8.
  8. Clark S., Costantine M., Hankins G. Review of NVP and HG and early pharmacotherapeutic intervention // Obstet. Gynecol. Int. – 2012; Article ID 252676, 8 p.
  9. ACOG (American College of Obstetrics and Gynecology). Practice Bulletin: nausea and vomiting of pregnancy // Obstet. Gynecol. – 2004; 103: 803–14.
  10. Kulida L.V., Majsina A.I., Peretjatko L.P. Rol' mitohondrial'noj disfunktsii v razvitii patologii platsenty // Mat' i ditja v Kuzbasse. – 2014; 2 (57): 28–32.
  11. Kuznetsova I.V., Konovalov V.A. Znachenie vitaminno-mineral'nyh kompleksov v obespechenii normal'nogo techenija beremennosti i razvitija ploda // Ginekologija. – 2015; 1: 72–6.
  12. Spiridonova N.V., Kaganova M.A., Solovova L.D. Metabolicheskaja terapija v kompleksnom lechenii rvoty beremennyh // Akusherstvo i ginekologija. – 2015; 12: 127–32.